Endotoxemia in immunotherapy with dendritic cell vaccine in patients with advanced cervical cancer

I. Goroshinskaya, A. Menshenina, E. Frantsiyants, I. Kaplieva, T. Moiseenko, E. Verenikina, L. Nemashkalova
{"title":"Endotoxemia in immunotherapy with dendritic cell vaccine in patients with advanced cervical cancer","authors":"I. Goroshinskaya, A. Menshenina, E. Frantsiyants, I. Kaplieva, T. Moiseenko, E. Verenikina, L. Nemashkalova","doi":"10.17709/2410-1893-2022-9-2-3","DOIUrl":null,"url":null,"abstract":"Purpose of the study. Assessment of albumin and endogenous intoxication levels in patients with locally advanced cervical cancer receiving immunotherapy with dendritic cell vaccine.Materials and methods. The study included 27 patients with advanced cervical cancer (CC) divided into 3 groups: 1) patients receiving dendritic cell vaccine (DCV) during primary chemoradiation treatment; 2) patients with the disease progression receiving DCV during second‑line chemotherapy; 3) patients with advanced disease with contraindications for chemo‑radiation treatment receiving DCV only. The comparison group included 20 healthy women. All groups were tested for levels of medium‑weight molecules (MWM254 and MWM280), total and effective concentrations of albumin (TCA and ECA), toxicity index (TI) characterizing the sorption capacity of albumin, and the coefficient of intoxication (CI) reflecting the balance between the accumulation and binding of toxic ligands.Results. Initial elevation of MWM was observed in all patients. Levels of MWM254 were the highest in patients with progression. TI in patients with primary and progressive CC was increased before the treatment by 1.7 and 2.2 times, and after CT (without DCV) – by 2.6 and 3.8 times. In group 3, TI was increased by 4 times, and CI by 2.5 times, being 81 % higher than in group 1. In primary patients, TI after 6 and 7 DCVs was similar to the normal values, and CI was increased during the treatment because of the accumulation of MWM254 due to disintegration of tumor masses in these patients, and then it was normalized after 7 DCVs. CI in patients of groups 2 and 3 decreased after each DCV session. 4 and more DCVs restored the functional activity of albumin and normalized the MWM content.Conclusion. Administration of DCV (at least 7–8 sessions) in CC patients receiving anticancer treatment or as monotherapy decreases endotoxicosis and restores detoxification capacity of albumin.","PeriodicalId":334809,"journal":{"name":"Research and Practical Medicine Journal","volume":"38 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research and Practical Medicine Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17709/2410-1893-2022-9-2-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose of the study. Assessment of albumin and endogenous intoxication levels in patients with locally advanced cervical cancer receiving immunotherapy with dendritic cell vaccine.Materials and methods. The study included 27 patients with advanced cervical cancer (CC) divided into 3 groups: 1) patients receiving dendritic cell vaccine (DCV) during primary chemoradiation treatment; 2) patients with the disease progression receiving DCV during second‑line chemotherapy; 3) patients with advanced disease with contraindications for chemo‑radiation treatment receiving DCV only. The comparison group included 20 healthy women. All groups were tested for levels of medium‑weight molecules (MWM254 and MWM280), total and effective concentrations of albumin (TCA and ECA), toxicity index (TI) characterizing the sorption capacity of albumin, and the coefficient of intoxication (CI) reflecting the balance between the accumulation and binding of toxic ligands.Results. Initial elevation of MWM was observed in all patients. Levels of MWM254 were the highest in patients with progression. TI in patients with primary and progressive CC was increased before the treatment by 1.7 and 2.2 times, and after CT (without DCV) – by 2.6 and 3.8 times. In group 3, TI was increased by 4 times, and CI by 2.5 times, being 81 % higher than in group 1. In primary patients, TI after 6 and 7 DCVs was similar to the normal values, and CI was increased during the treatment because of the accumulation of MWM254 due to disintegration of tumor masses in these patients, and then it was normalized after 7 DCVs. CI in patients of groups 2 and 3 decreased after each DCV session. 4 and more DCVs restored the functional activity of albumin and normalized the MWM content.Conclusion. Administration of DCV (at least 7–8 sessions) in CC patients receiving anticancer treatment or as monotherapy decreases endotoxicosis and restores detoxification capacity of albumin.
树突状细胞疫苗免疫治疗晚期宫颈癌患者的内毒素血症
研究目的:接受树突状细胞疫苗免疫治疗的局部晚期宫颈癌患者白蛋白和内源性中毒水平的评估材料和方法。研究纳入27例晚期宫颈癌(CC)患者,分为3组:1)首次放化疗期间接受树突状细胞疫苗(DCV)治疗的患者;2)疾病进展患者在二线化疗期间接受DCV;3)有放化疗禁忌症的晚期疾病患者仅接受DCV。对照组包括20名健康女性。检测各组小鼠中重分子(MWM254和MWM280)水平、白蛋白总浓度和有效浓度(TCA和ECA)、表征白蛋白吸附能力的毒性指数(TI)和反映毒性配体积累与结合平衡的中毒系数(CI)。所有患者均观察到MWM的初始升高。MWM254水平在进展患者中最高。原发性和进展性CC患者的TI在治疗前分别增加1.7倍和2.2倍,CT(无DCV)后分别增加2.6倍和3.8倍。3组TI提高4倍,CI提高2.5倍,均较1组提高81%。原发患者6、7 dcv后TI与正常值相近,治疗过程中CI升高,因患者肿瘤团块崩解导致MWM254积累,7 dcv后CI恢复正常。第2组和第3组患者在每次DCV治疗后CI下降。4个以上的dcv恢复了白蛋白的功能活性,使MWM含量正常化。在接受抗癌治疗或单药治疗的CC患者中给予DCV(至少7-8个疗程)可减少内毒素中毒并恢复白蛋白的解毒能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信